Back pain reduces Australia�s GDP by $3.2 Billion per annum with over $1 billion being spent each year on low back pain treatments. While it makes sense to devote resources to prevention, unfortunately most prevention strategies do not work.We need a new approach based upon a better understanding of what triggers an episode of back pain. By studying risk factors that occur immediately prior to an episode of low back pain this project will increase understanding of what triggers an episode and op ....Back pain reduces Australia�s GDP by $3.2 Billion per annum with over $1 billion being spent each year on low back pain treatments. While it makes sense to devote resources to prevention, unfortunately most prevention strategies do not work.We need a new approach based upon a better understanding of what triggers an episode of back pain. By studying risk factors that occur immediately prior to an episode of low back pain this project will increase understanding of what triggers an episode and open the way for new, effective prevention programs.Read moreRead less
Low back pain is a major global health problem and the leading cause of disability worldwide . This project will trial a new treatment for back pain that is specifically aimed at risk factors for developing ongoing back problems. Previously shown to be successful in patients suffering persistent back problems, this promising new treatment will be trialled in patients soon after they develop lower back pain as a preventative approach.
Why Do People Keep Hurting Their Back: A Longitudinal Study Of Biological, Psychological And Social Predictors
Funder
National Health and Medical Research Council
Funding Amount
$739,946.00
Summary
We aim to identify why people continue to suffer episodes of back pain. If we can identify factors that predict the course of back pain we can target treatments to the right people to reduce the burden of this common condition. We will follow people for a year after an acute episode. We will measure novel issues like control of trunk muscles, inflammatory response, and how the nervous system deals with pain. We will also investigate how these factors interact with social and psychological issues
Low back pain (LBP) is highly prevalent and enormously expensive to society: total payments made by Workcover for injuries to the low back were in excess of $530 million in NSW in 1996. Chronic LBP (pain lasting more than 3 months) accounts for up to 90% of these costs. Prevention of a large part of this costly problem could be achieved by effective treatment at the earlier sub-acute phase of LBP (6 weeks to 3 months duration). Exercise and advice are two widely-used treatments for sub-acute LBP ....Low back pain (LBP) is highly prevalent and enormously expensive to society: total payments made by Workcover for injuries to the low back were in excess of $530 million in NSW in 1996. Chronic LBP (pain lasting more than 3 months) accounts for up to 90% of these costs. Prevention of a large part of this costly problem could be achieved by effective treatment at the earlier sub-acute phase of LBP (6 weeks to 3 months duration). Exercise and advice are two widely-used treatments for sub-acute LBP, yet remarkably, their efficacy is unknown. For the first time, this study will rigorously evaluate the effectiveness of both a supervised exercise program and advice to return to normal activity for sub-acute LBP. When this study is completed, Australian practitioners will be able to adopt evidence based practice when managing sub-acute LBP. In addition, the study's results will enable practitioners to select the most effective treatment for each individual patient. The results of this study should lead to a large reduction in the incidence of chronic LBP, therefore the results should lead to significant savings in terms of social and economic costs.Read moreRead less
Improving Outcomes In Low Back Pain: Targeting Specific Therapies To Patient Subgroups
Funder
National Health and Medical Research Council
Funding Amount
$435,061.00
Summary
Low back pain is a major health problem worldwide. There is a lack of effective treatments and a “one size fits all” approach to treatment is being used. This innovative research program aims to change the way back pain is treated, by identifying specific types of back pain, determining the effectiveness of treatments for these types of back pain, and translating a targeted approach to management into clinical practice to improve the health of individuals with back pain.
INVESTIGATIONS ON THE REGULATION OF INTERVERTEBRAL DISC CELL MATRIX METALLOPROTEINASES
Funder
National Health and Medical Research Council
Funding Amount
$331,320.00
Summary
Degeneration of the intervertebral disc is a painful disabling condition with major socioeconomic consequences. Medical problems associated with disc degeneration and back-pain, of sufficient severity to warrant consultation with a physician, are experienced by 90% of the population some time during their lives. In man, back pain increases in incidence in the third and fourth decades of life, peaks in the fifties and declines thereafter. Changes in population demographics indicate this problem w ....Degeneration of the intervertebral disc is a painful disabling condition with major socioeconomic consequences. Medical problems associated with disc degeneration and back-pain, of sufficient severity to warrant consultation with a physician, are experienced by 90% of the population some time during their lives. In man, back pain increases in incidence in the third and fourth decades of life, peaks in the fifties and declines thereafter. Changes in population demographics indicate this problem will increase in severity over the next few decades. American Bureau of Census data indicate that between 1990 to 2010 the number of people >45 years will increase from 82 to 124 million, the number of elderly in emerging countries will also increase between 200 to 400% in the next 30 years. In the United States, back-pain is the second most common reason that people visit a physician and medical conditions related to back-pain account for more hospitalisations than any other musculoskeletal disorder. Despite its high incidence, associated problems of incapacity and economic implications, costed at $100 million per annum in Australia in 1992, and US$100 billion globally in 1999-2000 (Dorland Data Networks, PA, USA) the causes of low back-pain are still poorly understood. Disc disease is responsible for 23-40% of all cases of low back-pain. The management of discogenic low back-pain is currently empirical, directed either toward life-style changes to minimise symptomatology or to surgical resection or spinal arthrodesis to restrict articulation. Based on our recent findings and those of colleagues over the last 16 years, it is our strong conviction that it should be possible with a better understanding of disease mechanisms and with the use of modern technologies to inhibit, reverse or ideally prevent disc degeneration. Without such basic research there will be no scientific foundation upon which prospective therapies may be based.Read moreRead less
Why Do People Develop Chronic Low Back Pain? An Investigation Of Brain Function As A Predictor Of Chronic Low Back Pain.
Funder
National Health and Medical Research Council
Funding Amount
$96,631.00
Summary
Chronic low back pain is the most disabling condition worldwide. Two objective measures of brain function, electrical signals of brain activity (electroencephalography), and attentional bias observed with eye tracking technology will be measured in a group of participants with acute back pain. These measurements will provide objective markers of brain function that may be predictive of the transition from acute to chronic low back pain, providing new opportunities for treatment.